"Freigemeinnütziges Krankenhaus und Akademisches Lehrkrankenhaus der Medizinischen Fakultät der Universität Hamburg. Ein breites und hochspezialisiertes Leistungsspektrum im Herz- und Gefäßzentrum, Geburtszentrum, Tumorzentrum, Wirbesäulenzentrum, Neurologie und neurologische Frührehabilitation, Zentrale Notaufnahme, Altersmedizin, Chirurgie, Innere Medizin, Gynäkologie, Orthopädie und Unfallchirurgie, Psychiatrie und Psychotherapie, Radiologie, Urologie und Uroonkologie."

During the past decade, Albertinen Krankenhaus conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Albertinen Krankenhaus" #1 sponsor was "Medtronic Bakken Research Center" with 3 trials, followed by "Universitätsklinikum Hamburg-Eppendorf" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored, "MicroPort CRM" with 2 trials sponsored and "AGO Research GmbH" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Albertinen Krankenhaus" #1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "German Breast Group" with 2 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator and "Albertinen-Krankenhaus Hamburg" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Albertinen Krankenhaus" are "Heart Failure" (5 trials), "Ovarian Cancer" (3 trials), "Breast Cancer" (2 trials), "Aortic Valve Replacement" (1 trials) and "Aortic Valve Stenosis and/or Insufficiency" (1 trials). Many other conditions were trialed in "Albertinen Krankenhaus" in a lesser frequency.

Most popular intervention types in "Albertinen Krankenhaus" are "Device" (10 trials), "Drug" (8 trials), "Other" (3 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Carboplatin" (2 trials), "Abemaciclib + Aromatase Inhibitor" (1 trials), "Abemaciclib + Fulvestrant" (1 trials) and "Aortic implantation of Mosaic Ultra porcine bioprosthesis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Albertinen Krankenhaus" are 17 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Albertinen Krankenhaus". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Albertinen Krankenhaus, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Albertinen Krankenhaus, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".

Albertinen Krankenhaus has several departments that took part in Clinical trials: "Albertinen Herz- und Gefäßzentrum" - 2 trials